Work experience student makes cystic fibrosis breakthrough
Jo Armstead, 21, revealed a link between the condition and aspergillus
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A medical student on work experience has made a breakthrough in cystic fibrosis research that will improve treatment and could extend sufferers’ life expectancy.
Jo Armstead, 21, spent hundreds of hours at Wythenshawe Hospital in Manchester over the summer using data from 30 countries to examine the link between the debilitating lung condition and the aspergillus fungus.
She found that of more than 75,000 people with the genetic disorder studied, half had been infected with aspergillus.
What started out as a summer project has led to the research being published in a leading journal, the Public Library of Science, and recognition from experts.
Professor David Denning, who worked with Jo as the director of the NHS National Aspergillosis Centre, said although the life expectancy of people with cystic fiboris has been increasing, aspergillosis has a terrible impact on many.
He added: “By painstakingly crunching the numbers, Jo has helped us better understand the scale of the challenge which will lead to better diagnostics and treatment strategies.
“There will be many patients who over the coming years will be grateful to Jo and her work.”
Jo, from Altrincham, is in her third year at Newcastle University Medical School and is considering a career in acute medicine.
She said: “It has been really great to be involved in the first project of its kind ever done, with dramatic results and real opportunities for better health in young CF sufferers.”
Although cystic fibrosis sufferers are known to be at risk of aspergillosis, her research is the first to show the extent of the link.
The UK has the second highest number of adults with the condition – more than 5,200 - second only to the US.
Aspergillosis causes bronchitis and an allergy known as ABPA, which starts in childhood and reaches a peak in the teenage years.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments